Abstract
Objective: To review the risks and benefits of hormonal therapy in climacteric. Methods: A systematic bibliographic review was carried out to promote a basic, exploratory and qualitative study based on scientific articles. The data collection of this study essentially includes the search for articles published between the years 2006 to 2017 and indexed through the following databases: in which the following descriptors were applied: Climacteric, menopause, TH, benefits. Using the inclusion and exclusion criteria. Results: It was observed that the results found, based on post-menopausal articles / publications, in addition to loss of reproductive capacity, women's tissues and organs lose their support since it is ensured by estrogen, and it is necessary to replace lost hormones, mainly in order to offer a quality of life at this stage. Although the use of hormone therapy (HT) is often fraught with doubts, it has been considered as an important ally in relieving symptoms and reducing the onset of diseases at this stage of life, without risk. Conclusion: Postmenopausal hormone therapy is indicated for both therapeutic and prophylactic purposes, which may increase female longevity. Treatment should be individualized to identify the most appropriate type of hormonal therapy.